Geode Capital Management, Mizuho Securities, and Manufacturers Life Insurance Company increased their holdings and raised their target price/rating on MBX Biosciences stock.
1 report, 1 independent
Updated Aug 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Geode Capital Management, Mizuho Securities, and Manufacturers Life Insurance Company increased their holdings and raised their target price/rating on MBX Biosciences stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Geode Capital Management
American Investment Management firm based in Boston, Massachusetts
-
Mizuho Securities
Japanese investment banking company
Nothing else this week.
-
Manufacturers Life Insurance Company
business
Related events
- Geode Capital Management raised its position in Biofrontera stock on August 30, 2026.
- Geode Capital Management increased its stake in Sensient Technologies stock on September 10, 2026.
- Multiple financial firms, including Geode Capital Management and Goldman Sachs, issued rating changes and bought shares of MVB Financial Corp. on September 5, 2026.
- Geode Capital Management and Norges Bank increased their positions in Terreno Realty Corporation on September 26, 2026.
- Geode Capital Management, Norges Bank, and Renaissance Technologies raised their positions in Warner Music Group (WMG) stock on September 15, 2026.